Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Retained Earnings (2016 - 2022)

Edesa Biotech's Retained Earnings history spans 10 years, with the latest figure at -$41.2 million for Q2 2022.

  • For Q2 2022, Retained Earnings fell 80.76% year-over-year to -$41.2 million; the TTM value through Jun 2022 reached -$41.2 million, down 80.76%, while the annual FY2021 figure was -$26.5 million, 9125.37% down from the prior year.
  • Retained Earnings for Q2 2022 was -$41.2 million at Edesa Biotech, down from -$35.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$173413.0 in Q4 2021 and bottomed at -$53.5 million in Q1 2019.
  • The 5-year median for Retained Earnings is -$18.1 million (2021), against an average of -$20.5 million.
  • The largest annual shift saw Retained Earnings surged 99.33% in 2019 before it tumbled 9125.37% in 2021.
  • A 5-year view of Retained Earnings shows it stood at -$429973.0 in 2018, then grew by 24.66% to -$323960.0 in 2019, then surged by 43.27% to -$183777.0 in 2020, then rose by 5.64% to -$173413.0 in 2021, then crashed by 23675.98% to -$41.2 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Retained Earnings are -$41.2 million (Q2 2022), -$35.4 million (Q1 2022), and -$173413.0 (Q4 2021).